Log In
BCIQ
Print this Print this
 

CEA-expressing VRP vaccine (AVX701)

  Manage Alerts
Collapse Summary General Information
Company AlphaVax Inc.
DescriptionCEA(6D)-expressing virus-like replicon particle (VRP) immunotherapy
Molecular Target Carcinoembryonic antigen (CEA)
Mechanism of ActionImmunotherapy
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I/II
Standard Indication Cancer (unspecified)
Indication DetailsTreat advanced or metastatic CEA-expressing malignancies
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today